Ganirelix Acetate
- Product NDC
- 55566-1000
- 11-digit product format
- 555661000
- Labeler code
- 55566
- Product ID
- 55566-1000_f4a3b28e-e635-43db-be13-f59511220051
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ganirelix Acetate
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- FERRING PHARMACEUTICALS INC.
- Application
- ANDA204246
- Marketing category
- ANDA
- Marketing start
- 2019-01-01
- Marketing end
- 0000-00-00
- Substance
- GANIRELIX ACETATE
- Active strength
- 250 ug/.5mL
- Pharmacologic classes
- Decreased GnRH Secretion [PE],Gonadotropin Releasing Hormone Receptor Antagonist [EPC],Gonadotropin Releasing Hormone Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55566-1000-1 | 55566100001 | 1 BLISTER PACK in 1 CARTON (55566-1000-1) > 1 SYRINGE in 1 BLISTER PACK > .5 mL in 1 SYRINGE | 1 blister pack | 2019-01-01 | 0000-00-00 | No | No | Current |